Figure 1:A,B: Chest wall invasion of invasive ductal carcinoma , thorax-CT images, marked with blue arrow
C,D: Chest wall invasion of invasive ductal carcinoma , PET/ CT images.(SUVmax:6,4), marked with blue arrow
Figure 2:A: Macroscopic view of tumor after resection.
B: The intraoperative view of reconstruction with titanium bar andprolene mesh.
C,D: The intraoperative view of reconstruction with latissimus dorsi musculo cutaneous flap.
The improvement in chest wall stability explains the postoperative mortality rates being no greater than 2% [1-3]. There are two ways to close defects: prostheti corautologous tissue (pedicled muscular or musculocutaneous flaps) with excellent circulation support. There commended reconstruction methods are the closure of defects by synthetic materials polytetrafluoroethylene mesh, polypropylene mesh, polyester mesh, composite prosthesis- methyl methacrylate bone cement, etc....), titanium osteosynthesis materials, and autologous materials (bone grafts, muscular transpositions, etc....) . In our case we decided that the prosthetic titanium bar can stabilize the chest wall due to the size of the defect. Also for skin defect autologous musculo cutaneous flap were used..Thus providing a hybrid reconstruction using both synthetic and autologous grafts.
The rate of locally recurrent breast cancer after apparently complete excision of stage I or II disease is thought to be between 4% and 20% . Clear surgical margins important for local control in chestwall invasion of BC. 3-20% chest wall recurrence may reveal after mastectomy. It depends on number of axillary nodes involved. 30% of this tumors have distant metastasis at time of chest wall involve mentdiagnosis . However, a detailed analysis of isolated chest wall recurrence ssuggested that local recurrence was associated with a median survival of 5.6 years and a 10-year survival of 30% . In our case surgical margin was clear and there was no axillary node involvement and had no distant metastasis.
It is often thought that local breast cancer recurrence always indicates the presence of distant metastases .
Radiotherapy is indicated for patients under going mastectomy as surgical management for breast cancer treatment when clinical or pathologic tumor and nodal features predict risk of local/regional recurrence. Such features include: tumor size 5 cm, inadequate surgical margins; skin, facial, or skeletal muscle invasion; dermally lymphatic invasion; poorly differentiated tumor histology; four or more lymph nodes positive; gross extra capsulartum or nodal extension into soft tissues; and matted lymph nodes or enlarged lymph nodes> 2 cm. Patients who were treated with irradiation after mastectomy can develop local/regional recurrences despite such adjuvant therapy . But the best use of radiotherapy seems to be adjuvant post-operative treatment after R1 chest wall resection, a situation in which overall survival and disease free survival rates are then similar to those seen after R0 chest wallresection . The most important risk factor for failure of surgical resection in local recurrences is an insufficient safety margin. Confining there section of the soft tissues is associated with rerecurrence rates of upto 62% .
In conclusion; invasive ductal breast cancer can be arised by local recurrence even after many years. Recurrences developing in the chest wall can be successfully treated with synthetic and autologous grafts. Surgery should be prefered against other, less-aggressive treatments such as radiation therapy in appropriate patients
- SiahpushM, Singh GK. “Sociodemographic Variations in Breast Cancer Screening Behavior Among Australian Women: Results from The 1995 National Health Survey”.Preventive Medicine. 2002 Aug; 35(2): 174-180. (Ref.)
- D’Souza N, Darmanin G, Fedorowicz Z. Immediate versus delayed reconstruction following surgery for breast cancer. Cochrane Database Syst Rev. 2011 Jul;b (7):1-24. (Ref.)
- Pairolero PC. InShields TW, LoCicero J, Poon RB, eds. Chestwall reconstruction. General Thoracic Surgery. 5nd ed. Philadelphia: Williams &Wilkins; 2000. 599-608. (Ref.)
- AmesFC. BalchCM. Management of local and regional recurrence after mastectomy or breast-conserving treatment. Surg Clin North Am. 1990 Oct ;7(5): 1115-1124. (Ref.)
- Liberman L. Breast MR imaging in assessing extent of disease. Magn Reson ImagingClin N Am. 2006 Aug;14(3):339-349. (Ref.)
- Kamby, SengelovL. Pattern of dissemination and survival following isolated locol regional recurrence of breastcancer: a prospective study with more than 10 years of followup. Breast Cancer Res Treat. 1997 Sep; 45(2): 181-192 (Ref.)
- Friedel G, Kuipers T, Engel C, Schopf C, Veit S, et al. Full-thickness chestwall resection for locally recurrent breast cancer. Thorac Surg Sci .2005 Aug; 2: 1-5. . (Ref.)
- Taylor ME . Breast Cancer:Chest Wall Recurrences. Current Treatment Options in Oncology. 2002 Apr;3(2) :175–177(Ref.)
- Faneyte IF, Rutgers EJ, Zoetmulder FA. Chestwall resection in the treatment of locally recurrent breast carcinoma : indications and out come for 44 patients, Cancer . 1997 Sep; 80(5): 886-891. (Ref.)
- Probstfeld MR, O’Connell TX. Treatment of locally recurrent breast carcinoma, ArchSurg. 198 Oct;124(10): 1127-1129. (Ref.)